PHARMACIST PRESCRIBING MODEL GETS FURTHER SUPPORT FROM STATE HEALTH Training rolls out to support full scope of practice for pharmacists ready and interested
With
Kate Gunthorpe,
Pharmacist Implementation & Change Specialist
TerryWhite Chemmart &
Adjunct Lecturer & Examiner
James Cook University &
Pharmacist Prescriber,
Brisbane Metro, Rural and Regional
Esmond Biesiek-Wright, Pharmacist & Network Partner,
TerryWhite Chemmart Compounding Ainslie (ACT)
EARNED MEDIA SEGMENT
Filmed in Brisbane & Canberra | September 2025
Legislative and regulatory changes following the success of the pharmacist prescriber model in Queensland are continuing with NSW Premier Chris Minns in early September 2025 announcing additional training centres from 2026, making permanent pharmacist treatment for certain dermatological conditions and outlining plans to assess pharmacists prescribing antiviral medications for influenza.
A full scope pharmacist prescriber model allows pharmacists to independently prescribe medicines within their professional competence, without requiring prior doctor authorisation. It extends pharmacists’ role beyond dispensing to include assessment, diagnosis of minor and chronic conditions, initiation and modification of therapy, and ongoing patient monitoring. This model integrates pharmacists into primary care teams, aiming to improve timely access to treatment, reduce pressure on general practitioners, and enhance continuity of care. Pharmacists use their clinical knowledge, patient records, and collaborative pathways to ensure safe prescribing. The model emphasises training, regulation, and accountability to maintain high standards of patient safety.
Pharmacist prescribing plays a crucial role in alleviating the pressure on emergency services and general practitioners, allowing pharmacists to enhance their skills and job satisfaction while welcoming more pharmacy students into the workforce for fulfilling careers. Kate Gunthorpe, an Implementation and Change Specialist at TerryWhite Chemmart and a pharmacist prescriber serving Brisbane and its surrounding areas, points to a pilot program established in Far North Queensland that were the origins of the model. This initiative permitted pharmacists to autonomously prescribe for 22 common acute conditions without the need for GP intervention.
At present, Queensland stands at the forefront of full-scope pharmacist prescribing, with Northern Territory and Western Australia beginning educational programs to support this practice. Other regions, including Victoria, Tasmania, and South Australia, are developing similar programs, while Australian Capital Territory is expected to follow suit shortly in early 2026.
Esmond Biesiek-Wright, a partner pharmacist at TerryWhite Chemmart Compounding Ainslie, spoke to Australian Health Journal. He emphasises the importance of fostering collaboration with GPs, noting a shift from transactional interactions to more collegial relationships, to support the patient needs.
Since beginning her training for pharmacist prescribing through James Cook University, Kate is dedicated to ensuring her community benefits from these advancements and is optimistic about the future of pharmacist prescribing across Australia, promoting better health outcomes for all.
Source: Written by AUDIENCED
-
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
-
Forum fosters dialogue in breast cancer
In October 2024, the Frazier Institute hosted an event dedicated to breast cancer advocacy and research, supported by TRI (Translational Research Institute), National Breast Cancer Foundation, PA Research Foundation, Health Translation Queensland, QUT and The University of Queensland Faculty of Medicine/Frazer Institute.
The key aim of the event co-organised by Associate Professor Joy Wolfram, Group Leader, Australian Institute for Bioengineering and Nanotechnology & School of Chemical Engineering, The University of Queensland was to foster dialogue between breast cancer lived experience advocates (consumers), researchers, and clinicians.
-
Belonging in a medical device company
Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
